137 related articles for article (PubMed ID: 4881877)
1. Experience with a new butyrophenone derivative (Buronil).
Vangtorp A; Simmelsgaard H; Mellegaard M
Acta Psychiatr Scand Suppl; 1968; 203():235-8. PubMed ID: 4881877
[No Abstract] [Full Text] [Related]
2. [Buronil (FG 5111)--a new butyrophenone derivative. A controlled clinical study on senile dementia and confusion].
Simmelsgaard H; Mellergaard M; Vangtorp A
Nord Med; 1967 Feb; 77(7):210-3. PubMed ID: 5336427
[No Abstract] [Full Text] [Related]
3. [Buronil, a new butyrophenone derivative for acute psychiatric disorders. A comparison with chlorpromazine and chlorprothixene].
Haugen T
Ugeskr Laeger; 1967 Sep; 129(37):1194-7. PubMed ID: 5584977
[No Abstract] [Full Text] [Related]
4. Double-blind study with two butyrophenone derivatives: bromperidol vs. haloperidol.
Pöldinger W; Bures E; Haage H
Int Pharmacopsychiatry; 1977; 12(3):184-92. PubMed ID: 334688
[TBL] [Abstract][Full Text] [Related]
5. [Buronil and promazine therapy of patients with senile dementia. A double-blind study].
Engstrand E
Nord Psykiatr Tidsskr; 1967; 21(3):234-40. PubMed ID: 4871565
[No Abstract] [Full Text] [Related]
6. [Experience with Luvatren in ambulatory psychiatric patients].
Reiter PJ
Schweiz Arch Neurol Neurochir Psychiatr; 1969; 104(1):169-78. PubMed ID: 5801171
[No Abstract] [Full Text] [Related]
7. [Buronil in senile confusion and excitement. A double-blind study].
Norgård A; Tingsgaard P; Nielsen IL
Nord Psykiatr Tidsskr; 1967; 21(3):240-4. PubMed ID: 4871566
[No Abstract] [Full Text] [Related]
8. [Influencing of biological and immunologic pregnancy reactions by psychotropic drugs].
Radzuweit H; Knorr W
Endokrinologie; 1969; 54(1):111-7. PubMed ID: 5358570
[No Abstract] [Full Text] [Related]
9. Clinical evaluation of haloperidol in geriatric patients.
Tobin JM; Brousseau ER; Lorenz AA
Geriatrics; 1970 Jun; 25(6):119-22. PubMed ID: 4915764
[No Abstract] [Full Text] [Related]
10. [ year of experimentation with haloanisone, MD 2028, in geronto-psychiatry].
Villa JL; Pasini W
Praxis; 1966 Jan; 55(2):46-9. PubMed ID: 5952625
[No Abstract] [Full Text] [Related]
11. [Preliminary clinical observations on a new butyrophenone derivative: Dipiperon on Pipamperone (R-3345)].
Madalena JC
Hospital (Rio J); 1967 Jan; 71(1):73-8. PubMed ID: 5302873
[No Abstract] [Full Text] [Related]
12. CI-601, a butyrophenone derivative, in the treatment of chronically withdrawn schizophrenic patients.
Villeneuve C; Ananth JV; Ban TA; Lehmann HE
Curr Ther Res Clin Exp; 1970 Apr; 12(4):223-9. PubMed ID: 4985943
[No Abstract] [Full Text] [Related]
13. [Methylperone (Buronil) in anxiety states in the elderly].
Viskum P
Nord Med; 1970 Oct; 84(41):1298-9. PubMed ID: 5469321
[No Abstract] [Full Text] [Related]
14. New dystonic syndrome associated with butyrophenone therapy.
Ekbom K; Lindholm H; Ljungberg L
Z Neurol; 1972; 202(2):94-103. PubMed ID: 4115928
[No Abstract] [Full Text] [Related]
15. [Clinical trial with R-3345].
Bastos O; Carvalho RG
J Bras Psiquiatr; 1970; 19(3):251-6. PubMed ID: 4949175
[No Abstract] [Full Text] [Related]
16. A butyrophenone (haloperidol) for the treatment of institutionalized patients.
Lapolla A; Nash LR
Int J Neuropsychiatry; 1966 Apr; 2(2):129-34. PubMed ID: 5335397
[No Abstract] [Full Text] [Related]
17. Haloperidol and trifluperidol in psychiatry.
Drug Ther Bull; 1968 Jul; 6(15):58-9. PubMed ID: 5691291
[No Abstract] [Full Text] [Related]
18. [Report on the experience with the clinical use of Luvatren and Luvatren retard].
Matthée K
ZFA (Stuttgart); 1976 Dec; 52(34):1791-3. PubMed ID: 795206
[No Abstract] [Full Text] [Related]
19. [On the position of butyrophenone derivative Triperidol in psychiatric treatment].
Lange E; Scholz V
Psychiatr Neurol Med Psychol (Leipz); 1968 Jun; 20(6):202-7. PubMed ID: 5731875
[No Abstract] [Full Text] [Related]
20. Further studies of the butyrophenone, CI-601, in chronic schizophrenic patients.
Edwards JG; Simpson GM
Curr Ther Res Clin Exp; 1968 Oct; 10(10):520-8. PubMed ID: 4971467
[No Abstract] [Full Text] [Related]
[Next] [New Search]
